PACS Links
What is PACS?
What is a Field Reimbursement Specialist?
PACS reviews
Why certify?
PACS price
PACS recertification
PACS extension
PACS FAQs
Quick contact
info@acmainfo.org

Apr 20, 2026
5 minutes read
The COVID-19 pandemic has catalyzed a significant transformation in healthcare delivery and payer reimbursement policies. For market access professionals, field reimbursement managers (FRMs), and prior authorization specialists, understanding these dynamic shifts is crucial for optimizing patient access and navigating the complexities of interactions with payers. This article delves into recent changes in reimbursement frameworks that have emerged following the pandemic, highlighting practical strategies to adapt workflows and enhance stakeholder engagement.
The pandemic significantly influenced payer reimbursement policies, particularly concerning telehealth and digital health services. In 2020, the Centers for Medicare & Medicaid Services (CMS) put in place emergency measures to expand access to telehealth. These adaptations have since evolved into permanent policy changes aimed at reducing systemic barriers to care and streamlining reimbursement processes. As highlighted in post-pandemic healthcare analyses (e.g., Health Affairs), the need for operational flexibility in reimbursement strategies has never been more critical.
Field reimbursement managers are instrumental in implementing new strategies that align with evolving payer policies. Critical operational adaptations include:

Apr 20, 2026
5 minutes read
The COVID-19 pandemic has catalyzed a significant transformation in healthcare delivery and payer reimbursement policies. For market access professionals, field reimbursement managers (FRMs), and prior authorization specialists, understanding these dynamic shifts is crucial for optimizing patient access and navigating the complexities of interactions with payers. This article delves into recent changes in reimbursement frameworks that have emerged following the pandemic, highlighting practical strategies to adapt workflows and enhance stakeholder engagement.
The pandemic significantly influenced payer reimbursement policies, particularly concerning telehealth and digital health services. In 2020, the Centers for Medicare & Medicaid Services (CMS) put in place emergency measures to expand access to telehealth. These adaptations have since evolved into permanent policy changes aimed at reducing systemic barriers to care and streamlining reimbursement processes. As highlighted in post-pandemic healthcare analyses (e.g., Health Affairs), the need for operational flexibility in reimbursement strategies has never been more critical.
Field reimbursement managers are instrumental in implementing new strategies that align with evolving payer policies. Critical operational adaptations include:
Effective communication among stakeholders is crucial for resolving access bottlenecks. Understanding payer motivations and developing educational resources tailored for providers can dramatically enhance outcomes:
The transition to telehealth has necessitated updates to prior authorization procedures across both federal and commercial payers. CMS is actively revising these protocols, optimizing them to support digital care models. Reimbursement professionals must remain proactive regarding these adjustments, which frequently enhance electronic prior authorization (ePA) submissions and expedite processing timelines.
Consider a situation where a primary care physician submits a prior authorization request for a specialized therapy that is initially rejected due to inadequate documentation. An FRM can facilitate the overturn through the following structured steps:
As reimbursement models evolve toward value-based care (VBC), market access professionals must adopt comprehensive strategies reflecting this shift, prioritizing clinical quality and cost-efficiency in healthcare delivery:
The landscape of payer reimbursement policies continues to transform in the wake of the COVID-19 pandemic, presenting both challenges and strategic opportunities for market access professionals. By leveraging operational adaptations, fostering stakeholder engagement, and aligning strategies with evolving payer expectations, FRMs and authorization specialists can proficiently navigate this complex environment.
Key strategies to consider include:
Staying abreast of these developments enables access professionals to optimize workflows, mitigate delays, and ensure timely patient access to critical therapies.
Standard administrative appeals typically take between 14 to 30 days, depending on state regulations and individual payer policies. However, for urgent or time-sensitive clinical cases, expedited/urgent appeals are subject to statutory mandates—such as CMS requirements—that dictate decision turnarounds within 72 hours (or 24 to 72 hours for many commercial plans).
No. Field Reimbursement Managers occupy commercial roles and are strictly prohibited by FDA guidance, the False Claims Act, and Anti-Kickback regulations from proactively discussing, promoting, or presenting data on off-label drug uses. Any off-label inquiries from healthcare providers must be referred directly to Medical Science Liaisons (MSLs) or Medical Affairs, who may only address off-label topics in response to an unsolicited request.
Staying informed through authoritative sources such as the Centers for Medicare & Medicaid Services (CMS), state insurance commissioner portals, professional organizations (e.g., AAPC, NAMCP), and healthcare policy publications offers critical insights into evolving payer policies and billing codes.
Effective communication among stakeholders is crucial for resolving access bottlenecks. Understanding payer motivations and developing educational resources tailored for providers can dramatically enhance outcomes:
The transition to telehealth has necessitated updates to prior authorization procedures across both federal and commercial payers. CMS is actively revising these protocols, optimizing them to support digital care models. Reimbursement professionals must remain proactive regarding these adjustments, which frequently enhance electronic prior authorization (ePA) submissions and expedite processing timelines.
Consider a situation where a primary care physician submits a prior authorization request for a specialized therapy that is initially rejected due to inadequate documentation. An FRM can facilitate the overturn through the following structured steps:
As reimbursement models evolve toward value-based care (VBC), market access professionals must adopt comprehensive strategies reflecting this shift, prioritizing clinical quality and cost-efficiency in healthcare delivery:
The landscape of payer reimbursement policies continues to transform in the wake of the COVID-19 pandemic, presenting both challenges and strategic opportunities for market access professionals. By leveraging operational adaptations, fostering stakeholder engagement, and aligning strategies with evolving payer expectations, FRMs and authorization specialists can proficiently navigate this complex environment.
Key strategies to consider include:
Staying abreast of these developments enables access professionals to optimize workflows, mitigate delays, and ensure timely patient access to critical therapies.
Standard administrative appeals typically take between 14 to 30 days, depending on state regulations and individual payer policies. However, for urgent or time-sensitive clinical cases, expedited/urgent appeals are subject to statutory mandates—such as CMS requirements—that dictate decision turnarounds within 72 hours (or 24 to 72 hours for many commercial plans).
No. Field Reimbursement Managers occupy commercial roles and are strictly prohibited by FDA guidance, the False Claims Act, and Anti-Kickback regulations from proactively discussing, promoting, or presenting data on off-label drug uses. Any off-label inquiries from healthcare providers must be referred directly to Medical Science Liaisons (MSLs) or Medical Affairs, who may only address off-label topics in response to an unsolicited request.
Staying informed through authoritative sources such as the Centers for Medicare & Medicaid Services (CMS), state insurance commissioner portals, professional organizations (e.g., AAPC, NAMCP), and healthcare policy publications offers critical insights into evolving payer policies and billing codes.